Description
To discuss the role of a pediatric physiatrist in management of patients with dystrophinopathy today with the newest treatments.
Learning Objectives
After completing this live course, the participant should be able to:
- To discuss the role of a pediatric physiatrist in caring for patients with dystrophinopathy
- To review important knowledge around current treatments and things physiatrists should monitor
Accreditation Statement
The American Academy of Physical Medicine and Rehabilitation (AAPM&R) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CME Credit Designation
The American Academy of Physical Medicine and Rehabilitation (AAPM&R) designates this live course for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Statement
In accordance with ACCME’s Standards for Integrity and Independence in Accredited Continuing Education, AAPM&R requires all individuals who are in a position to affect the strategic direction of AAPM&R and/or control the content of an educational activity to disclose all financial relationships with any ineligible company within the last 24 months. The ACCME defines an “ineligible company” as any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Disclosures are made in written form prior to the start of the educational activity, and any potential conflicts of interest that exist are mitigated prior to the start of the activity through AAPM&R’s Conflict of Interest Disclosure and Resolution Policy Process. Individuals in a position to affect the strategic direction of AAPM&R and/or control content and their disclosed financial relationships are listed below.
No other planners, faculty, or individuals in control of content disclosed any relevant financial relationships. Through the planning process, all relevant financial relationships have been mitigated.
Principle Faculty
Susan Apkon, MD, FAAPMR:Disclosed no relevant financial relationships.
AAPM&R Medical Education Committee
Rachel A. Brakke Holman, MD, Chair: Disclosed no relevant financial relationships.
Sarah M. Eickmeyer, MD: Disclosed no relevant financial relationships.
Chelsea D. Frost, MD, MS: Disclosed no relevant financial relationships.
David J. Haustein, MD, MBA: PM Consulting, Expert Medical Consulting: Ownership or Partnership; Greene
County Medical Society Executive Council, Missouri State Medical Foundation Board: Non-remunerative Positions of Influence
Sarah K. Hwang, MD: Disclosed no relevant financial relationships.
Ravi E. Kasi, MD: Disclosed no relevant financial relationships.
Caroline Pupke, DO: Disclosed no relevant financial relationships.
Monica E. Rho, MD: Disclosed no relevant financial relationships.
McCasey R. Smith, MD: Disclosed no relevant financial relationships.
Jennifer A. Soo Hoo, MD: Disclosed no relevant financial relationships.
Brionn K. Tonkin, MD: Disclosed no relevant financial relationships.
Stephanie Tow, MD: Disclosed no relevant financial relationships.
Justin L. Weppner, DO: Disclosed no relevant financial relationships.
Alexandra G. Wolfe, DO: Disclosed no relevant financial relationships.
FDA Disclosures
Any faculty member for this activity who intends to discuss or demonstrate any pharmaceutical or medical device for which FDA clearance has not been approved, will verbally disclose the FDA’s classification at the beginning of their presentation or demonstration.